GenomiCare Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GenomiCare Biotechnology - overview
Established
2015
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Based in Shanghai, China and established in 2015, GenomiCare Biotechnology is a medical services provider which focuses on tumor precision medicine, providing filtering, implementation and monitoring of it for patients.
Current Investors
5Y Capital, Apricot Capital, Jiaxin Holdings
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment
Website
www.genomicarebio.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.